Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.
The target company is a drug discovery contract research organisation.
The acquirer company expects the acquisition to help grow its pipeline.
China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province.
The purchase consideration for the transaction is expected to be CNY286.2m ($42.05m).
See Also:
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData